Potential risks associated with high-dose valproate in pregnancy in psychiatric patients [4]

Australian and New Zealand Journal of Psychiatry

Volumn 39, Issue 6, 2005, Pages 526-527

  Vajda, F J E ^a,b,c   Solinas, Carlo ^d  

^a MONASH UNIVERSITY   (Australia)

^b Australian Registry of Pregnancies on Antiepileptic Drugs ^*  (Australia)

^c Epilepsy Society of Australian   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

BIPOLAR DISORDER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FETUS MALFORMATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL PATIENT; MONOTHERAPY; PREGNANCY; PSYCHIATRIST; REGISTER; SEIZURE; STATISTICAL ANALYSIS;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; TRIAZINES; VALPROIC ACID;

EID: 21644478295     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2005.01613_6.x     Document Type: Letter

References (4)

1. Vajda FJE, Lander CM, Cook M et al. Report of the Australian Pregnancy Registry of women on antiepileptic drugs after 52 months. European Journal of Neurology 2004; 11(Suppl 2):21.
2. Vajda F, Lander C, O'Brien T et al. Australian Pregnancy Registry of women on antiepileptic drugs. Epilepsia 2004; 45:1.
3. Vajda FJ, Lander CM, Cook M et al. Australian Registry of Pregnancy of women on antiepileptic drugs [Abstract]. Journal of Neurology 2004; 251(Suppl 3):48.
4. Vajda FJE, OB'rien TJ, Hitchcock A et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of antiepileptic drugs in pregnancy. Journal of Clinical Neuroscience 2004 (in press) (available on line).